Emcure Pharmaceuticals, a leading pharma company with a strong focus on women’s healthcare, achieved a significant milestone on World Diabetes Day, making it to the Asia Book of Records for orchestrating the largest virtual diabetes awareness campaign focused on women's health. The record-setting initiative brought
Granules India Limited, a leading pharmaceutical manufacturing company, is pleased to announce that it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for its Unit V facility located at Jawaharlal Nehru Pharma City (JNPC), Anakapalli District, Parawada Mandal,
Under the Production Linked Incentive (PLI) scheme, Lyfius Pharma Private Limited (Lyfius Pharma) invested ₹2,500 crores in Penicillin-G (Pen-G) facility Commercial production to ramp up in FY25, enhancing domestic production of critical Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs) Lyfius Pharma
Mankind Pharma Limited has completed the transaction to acquire 100% stake in Bharat Serums and Vaccines Limited (BSV), for a purchase consideration of INR 13,768 Crores. This strategic move marks a significant leap for Mankind Pharma, positioning it as a market leader in the Indian
OneSource Specialty Pharma, a newly formed CDMO, is formed from the merger of three CDMO businesses within the Strides Group, which boasts a 30-year track-record of excellence in manufacturing and quality. The company is launching its new brand identity with a strong emphasis on customer
Fluoxetine Tabs 60 mg approval solidifies the Company's position in the molecule by complementing the recent approval in April 2024 for Fluoxetine 10 mg and 20 mg tablets and Fluoxetine capsules Strides Pharma Science Limited (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma
Strides Pharma Science Limited (Strides) today announced that it has secured the approval of its equity shareholders and secured creditors with overwhelming majority , along with those of OneSource Specialty Pharma Limited and SteriScience Specialties Private Limited, in meetings convened under the guidance of the
Since July 2023 only 14 serious international complaints received , being future ready for coming winter season more than 8000 batches of cough syrup tested and only 2-3 per cent failures found The Central Drugs Standard Control Organization (CDSCO) announced a low failure rate of just
Lupin Limited announced on Thursday the launch of its generic cancer treatment drug in the US market. The Mumbai-based pharmaceutical firm has introduced Doxorubicin Hydrochloride Liposome Injection in single-dose vials. This launch follows the approval from the US Food and Drug Administration (FDA) received by Lupin’s
The Three day International Exhibition For Pharma And Healthcare Exhibition (IPHEX 2024) begins More than 400 Major Indian pharma companies to showcase their pharmaceutical products and Technologies at the expo More than 400 foreign buyers from across the world to attend .India exported pharma products worth
